Caroline S. Foo
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Molecular Medicine top 10%
Papers in ⓘ
-
- SARS-CoV-2 and COVID-19 Research 8
- COVID-19 Clinical Research Studies 6
- Tuberculosis Research and Epidemiology 5
- SARS-CoV-2 detection and testing 2
-
- Cancer therapeutics and mechanisms 6
- Phenothiazines and Benzothiazines Synthesis and Activities 3
- Biochemical and Molecular Research 2
- Co-authors
- Stewart T. Cole (6 shared papers)Jérémie Piton (5 shared papers)Andréanne Lupien (6 shared papers)Johan Neyts (9 shared papers)Rana Abdelnabi (8 shared papers)Birgit Weynand (7 shared papers)Piet Maes (4 shared papers)Steven De Jonghe (5 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Nature Communications (2 papers)Antiviral Research (2 papers)Molecular Therapy (1 paper)PLoS Pathogens (1 paper)
- Partner nations
- BelgiumUnited StatesSwitzerland
In The Last Decade
Caroline S. Foo
17 papers receiving 787 citations
Peers
Comparison fields: 5 of 80
- Infectious Diseases 572
- Molecular Medicine 38
- Neurology 98
- Epidemiology 184
- Molecular Biology 312
Countries citing papers authored by Caroline S. Foo
This map shows the geographic impact of Caroline S. Foo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline S. Foo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline S. Foo more than expected).
Fields of papers citing papers by Caroline S. Foo
This network shows the impact of papers produced by Caroline S. Foo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline S. Foo. The network helps show where Caroline S. Foo may publish in the future.
Co-authors
The 25 scholars most cited alongside Caroline S. Foo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 92 | |
| 2 | 2022 | 84 | |
| 3 | 2021 | 67 | |
| 4 | 2022 | 65 | |
| 5 | 2016 | 64 | |
| 6 | 2014 | 60 | |
| 7 | 2018 | 54 | |
| 8 | 2018 | 52 | |
| 9 | 2018 | 52 | |
| 10 | 2022 | 40 | |
| 11 | 2016 | 40 | |
| 12 | 2020 | 37 | |
| 13 | 2020 | 35 | |
| 14 | 2021 | 35 | |
| 15 | 2022 | 12 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 4 |
About Caroline S. Foo
Caroline S. Foo is a scholar working on Infectious Diseases, Molecular Biology, Organic Chemistry, Epidemiology and Modeling and Simulation, having authored 17 papers that have together received 799 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), Cancer therapeutics and mechanisms (6 papers), COVID-19 Clinical Research Studies (6 papers), Tuberculosis Research and Epidemiology (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Biochemical and Molecular Research (2 papers), COVID-19 epidemiological studies (2 papers) and SARS-CoV-2 detection and testing (2 papers). The work is most often cited by research in Infectious Diseases (572 citations), Molecular Medicine (38 citations), Neurology (98 citations), Epidemiology (184 citations) and Molecular Biology (312 citations). Caroline S. Foo has collaborated with scholars based in Belgium, United States and Switzerland. Frequent co-authors include Stewart T. Cole, Jérémie Piton, Andréanne Lupien, Johan Neyts, Rana Abdelnabi, Birgit Weynand, Piet Maes, Steven De Jonghe, Anthony Vocat and Kévin Pethe. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Nature Communications, Antiviral Research, Molecular Therapy and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.